Soluble FGL2 induced by tumor necrosis factor-α and interferon-γ in CD4+ T cells through MAPK pathway in human renal allograft acute rejection

Journal of Surgical Research

Volumn 184, Issue 2, 2013, Pages 1114-1122

  Zhao, Zitong ^a,b   Wang, Lingyan ^a   Yang, Cheng ^a,b   Zhao, Tian ^a,b   Li, Long ^a,b   Hu, Linkun ^c   Wu, Duojiao ^b   Rong, Ruiming ^a,b   Xu, Ming ^a,b   Zhu, Tongyu ^a,b  

^a FUDAN UNIVERSITY   (China)

^b Shanghai Key Laboratory of Organ Transplantation   (China)

^c SOOCHOW UNIVERSITY   (China)

Author keywords

CD4+ T cells; MAPK pathway; Renal allograft rejection; Soluble FGL2; TNF and IFN

Indexed keywords

GAMMA INTERFERON; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN; SOLUBLE FIBRINOGEN LIKE PROTEIN 2; STRESS ACTIVATED PROTEIN KINASE; SYNAPTOPHYSIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ACUTE GRAFT REJECTION; ADULT; ARTICLE; CD4+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GRAFT RECIPIENT; HUMAN; IN VITRO STUDY; IN VIVO STUDY; KIDNEY ALLOGRAFT; KIDNEY BIOPSY; KIDNEY FUNCTION; KIDNEY GRAFT; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN SECRETION; RECIPIENT;

CD4(+) T CELLS; MAPK PATHWAY; RENAL ALLOGRAFT REJECTION; SOLUBLE FGL2; TNF-Α AND IFN-Γ;

ADULT; ALLOGRAFTS; CD4-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; FEMALE; FIBRINOGEN; GRAFT REJECTION; HUMANS; INTERFERON-GAMMA; KIDNEY TRANSPLANTATION; MALE; MAP KINASE SIGNALING SYSTEM; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; PHOSPHORYLATION; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84883896566     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2013.04.011     Document Type: Article

References (45)

1. Z.M. El-Zoghby, M.D. Stegall, and D.J. Lager Identifying specific causes of kidney allograft loss Am J Transplant 9 2009 527
2. C. Ponticelli The mechanisms of acute transplant rejection revisited J Nephrol 25 2012 150
3. N. Safinia, B. Afzali, K. Atalar, G. Lombardi, and R.I. Lechler T-cell alloimmunity and chronic allograft dysfunction Kidney Int Suppl 2010 S2
4. S. Marazzi, S. Blum, and R. Hartmann Characterization of human fibroleukin, a fibrinogen-like protein secreted by T lymphocytes J Immunol 161 1998 138
5. C. Ruegg, and R. Pytela Sequence of a human transcript expressed in T-lymphocytes and encoding a fibrinogen-like protein Gene 160 1995 257
6. S. Yuwaraj, J. Ding, M. Liu, P.A. Marsden, and G.A. Levy Genomic characterization, localization, and functional expression of FGL2, the human gene encoding fibroleukin: a novel human procoagulant Genomics 71 2001 330
7. Q. Ning, Y. Sun, and M. Han Role of fibrinogen-like protein 2 prothrombinase/fibroleukin in experimental and human allograft rejection J Immunol 174 2005 7403
8. M. Mendicino, M. Liu, and A. Ghanekar Targeted deletion of Fgl-2/fibroleukin in the donor modulates immunologic response and acute vascular rejection in cardiac xenografts Circulation 112 2005 248
9. A. Ghanekar, M. Mendicino, and H. Liu Endothelial induction of fgl2 contributes to thrombosis during acute vascular xenograft rejection J Immunol 172 2004 5693
10. N. Selzner, H. Liu, and M.U. Boehnert FGL2/fibroleukin mediates hepatic reperfusion injury by induction of sinusoidal endothelial cell and hepatocyte apoptosis in mice J Hepatol 56 2012 153
11. I. Shalev, H. Liu, and C. Koscik Targeted deletion of fgl2 leads to impaired regulatory T cell activity and development of autoimmune glomerulonephritis J Immunol 180 2008 249
12. A.E. Herman, G.J. Freeman, D. Mathis, and C. Benoist CD4+CD25+ T regulatory cells dependent on ICOS promote regulation of effector cells in the prediabetic lesion J Exp Med 199 2004 1479
13. J.D. Fontenot, J.P. Rasmussen, M.A. Gavin, and A.Y. Rudensky A function for interleukin 2 in Foxp3-expressing regulatory T cells Nat Immunol 6 2005 1142
14. L.M. Williams, and A.Y. Rudensky Maintenance of the Foxp3-dependent developmental program in mature regulatory T cells requires continued expression of Foxp3 Nat Immunol 8 2007 277
15. E.M. Shevach Mechanisms of foxp3+ T regulatory cell-mediated suppression Immunity 30 2009 636
16. Z. Zhao, C. Yang, and Q. Tang Serum level of soluble fibrinogen-like protein 2 in renal allograft recipients with acute rejection: a preliminary study Transplant Proc 44 2012 2982
17. T.L. Spivey, L. Uccellini, and M.L. Ascierto Gene expression profiling in acute allograft rejection: challenging the immunologic constant of rejection hypothesis J Transl Med 9 2011 174
18. J.M. Kyriakis, and J. Avruch Mammalian MAPK signal transduction pathways activated by stress and inflammation: a 10-year update Physiol Rev 92 2012 689
19. G. Huang, L.Z. Shi, and H. Chi Regulation of JNK and p38 MAPK in the immune system: signal integration, propagation and termination Cytokine 48 2009 161
20. I.D. McGilvray, Z. Lu, and A.C. Wei Murine hepatitis virus strain 3 induces the macrophage prothrombinase fgl-2 through p38 mitogen-activated protein kinase activation J Biol Chem 273 1998 32222
21. M. Liu, M. Mendicino, and Q. Ning Cytokine-induced hepatic apoptosis is dependent on FGL2/fibroleukin: the role of Sp1/Sp3 and STAT1/PU.1 composite cis elements J Immunol 176 2006 7028
22. K. Solez, R.B. Colvin, and L.C. Racusen Banff 07 classification of renal allograft pathology: updates and future directions Am J Transplant 8 2008 753
23. T. Zhao, C. Yang, and Y. Xue Impact of basiliximab on the proportion of regulatory T cells and their subsets early after renal transplantation: a preliminary report Transplant Proc 44 2012 175
24. T. Koyama, L.R. Hall, W.G. Haser, S. Tonegawa, and H. Saito Structure of a cytotoxic T-lymphocyte-specific gene shows a strong homology to fibrinogen beta and gamma chains Proc Natl Acad Sci U S A 84 1987 1609
25. L. Shao, D. Wu, and P. Zhang The significance of microthrombosis and fgl2 in no-reflow phenomenon of rats with acute myocardial ischemia/reperfusion Clin Appl Thromb Hemost 19 2013 19
26. J.W. Ding, Q. Ning, and M.F. Liu Fulminant hepatic failure in murine hepatitis virus strain 3 infection: tissue-specific expression of a novel fgl2 prothrombinase J Virol 71 1997 9223
27. G.A. Levy, M. Liu, and J. Ding Molecular and functional analysis of the human prothrombinase gene (HFGL2) and its role in viral hepatitis Am J Pathol 156 2000 1217
28. Y. Ding, K. Liu, and Y. Wang Expression and significance of fgl2 prothrombinase in cardiac microvascular endothelial cells of rats with type 2 diabetes J Huazhong Univ Sci Technolog Med Sci 30 2010 575
29. Y. Liu, L. Xu, and Q. Zeng Downregulation of FGL2/prothrombinase delays HCCLM6 xenograft tumour growth and decreases tumour angiogenesis Liver Int 32 2012 1585
30. L.G. Hidalgo, and P.F. Halloran Role of IFN-gamma in allograft rejection Crit Rev Immunol 22 2002 317
31. I.S. Grewal Overview of TNF superfamily: a chest full of potential therapeutic targets Adv Exp Med Biol 647 2009 1
32. K. Kichian, F.P. Nestel, D. Kim, P. Ponka, and W.S. Lapp IL-12 p40 messenger RNA expression in target organs during acute graft-versus-host disease. Possible involvement of IFN-gamma J Immunol 157 1996 2851
33. G. Das, S. Sheridan, and C.A. Janeway Jr. The source of early IFN-gamma that plays a role in Th1 priming J Immunol 167 2001 2004
34. P.J. McLaughlin, A. Aikawa, and H.M. Davies Evaluation of sequential plasma and urinary tumor necrosis factor alpha levels in renal allograft recipients Transplantation 51 1991 1225
35. S.E. Dorge, P. Roux-Lombard, and J.M. Dayer Plasma levels of tumor necrosis factor (TNF) and soluble TNF receptors in kidney transplant recipients Transplantation 58 1994 1000
36. K. Su, F. Chen, and W.M. Yan Fibrinogen-like protein 2/fibroleukin prothrombinase contributes to tumor hypercoagulability via IL-2 and IFN-gamma World J Gastroenterol 14 2008 5980
37. W.W. Hancock, F.M. Szaba, and K.N. Berggren Intact type 1 immunity and immune-associated coagulative responses in mice lacking IFN gamma-inducible fibrinogen-like protein 2 Proc Natl Acad Sci U S A 101 2004 3005
38. A. Plotnikov, E. Zehorai, S. Procaccia, and R. Seger The MAPK cascades: signaling components, nuclear roles and mechanisms of nuclear translocation Biochim Biophys Acta 1813 2011 1619
39. Y. Liu, S. Xu, and F. Xiao The FGL2/fibroleukin prothrombinase is involved in alveolar macrophage activation in COPD through the MAPK pathway Biochem Biophys Res Commun 396 2010 555
40. I.L. Noronha, M. Eberlein-Gonska, and B. Hartley In situ expression of tumor necrosis factor-alpha, interferon-gamma, and interleukin-2 receptors in renal allograft biopsies Transplantation 54 1992 1017
41. M. Han, W. Yan, and W. Guo Hepatitis B virus-induced hFGL2 transcription is dependent on c-Ets-2 and MAPK signal pathway J Biol Chem 283 2008 32715
42. E.K. Kim, and E.J. Choi Pathological roles of MAPK signaling pathways in human diseases Biochim Biophys Acta 1802 2010 396
43. S. Wang, Z.X. Zhang, and Z. Yin Anti-IL-2 receptor antibody decreases cytokine-induced apoptosis of human renal tubular epithelial cells (TEC) Nephrol Dial Transplant 26 2011 2144
44. C.Y. Nguan, and C. Du Renal tubular epithelial cells as immunoregulatory cells in renal allograft rejection Transplant Rev (Orlando) 23 2009 129
45. R. Oberbauer, M. Rohrmoser, H. Regele, F. Muhlbacher, and G. Mayer Apoptosis of tubular epithelial cells in donor kidney biopsies predicts early renal allograft function J Am Soc Nephrol 10 1999 2006